FiberCell Systems HFBR allows the production of about 50–200 mg of antibody per week using the medium-sized reactor (. no. C2011 or C5011). Two MAbs produced in Dulbecco s modified Eagle s medium (DMEM) and CDM-HD media were treated as above. The protein concentration of the dialyzed supernatants was quantified and their purity was checked on a 12 sodium dodecyl sulfate Cited by 66
· cGMP Production Bioreactors Applikon Biotechnology is the global specialist for human vaccine production systems and their bioreactors starting from Discovery to Production scale seamlessly enable optimization of the development of product to market.Cited by 135
· For many years the potential of immunoglobulin M (IgM) antibodies was not fully understood because of characteristics different to the well-known immunoglobulin G type like low target affinity cross reactivity and complex protein structure. In the meanwhile IgMs have been positively evaluated for their use as therapeutic agent in the mucosal environment but also in serum to eradicate · manufacturing driven largely by downstream processing consumable material costs this can reach up to 25 percent of the sales revenue for the drug. The majority of biotherapeutic mAbs and their derivatives are all produced by a similar set of methods. They are recombinant proteins and are most often produced in batch-fed mammalian
NanHuan Road, GongYi City, Henan Province, China
R&G Company is the focus on the development, production and sales of professional teaching equipment manufacturers. The main production of organic synthesis device, high and low temperature cycle device, double glass reactor, micro-melting point detector, circulating water type multi-purpose vacuum pump, glass instrument air dryer, low temperature coolant circulating pump and so on
Copyright © . R&G Instrument All rights reserved. | sitemap |